Didier Blaise

Has grant

Professor of Medicine

Aix-Marseille University

France

Research Interests

Explore related searches

Professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Didier Blaise is a Professor of Medicine at Aix-Marseille Université in France. His research primarily focuses on hematopoietic stem cell transplantation, particularly in older patients with various types of leukemia and myeloid neoplasms. He has contributed extensively to studies on transplantation outcomes and the efficacy of different donor types, as demonstrated in his recent articles with the Acute Leukemia Working Party of the EBMT.

Recent Grants

Grant: Close

Prospective and multicentre evaluation of 3 different doses of IV busulfan associated with fludarabine and thymoglobuline in the conditioning of allogeneic stem cell transplantation (SCT) from a matched related or unrelated donor in patients with poor risk myeloïd malignancies

Open Date: 2012-11-09

Close Date: 2016-09-10

Grant: Close

Phase I of infusion of selected donor NK cells after HLA identical allogeneic stem cell transplantation prepared with reduced intensity conditioning

Open Date: 2010-06-01

Close Date: 2013-06-01

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Nicolas Boissel

Université Paris Cité

FRANCE

View details

Abdul Hamid Bazarbachi

Columbia University Irving Medical Center

UNITED STATES

View details

Ibrahim Yakoub-Agha

Professeur des Universités - Praticien Hospitalier

Centre Hospitalier Régional Universitaire de Lille

FRANCE

View details

Nelson Chao

Duke University

UNITED STATES

View details

Javier Briones Meijide

Professor

University of Barcelona

SPAIN

View details

Emanuele Angelucci

Hematology and Transpalnt Center Head

Ospedale Policlinico San Martino

ITALY

View details

Jaime Sanz

Profesor asociado asistencial

Universidad Católica de Valencia Facultad de Medicina

SPAIN

View details

Cristina CASTILLA LLORENTE

Institut Gustave Roussy

FRANCE

View details

Nicolaus Kröger

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Didier Blaise

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (29)

Allogeneic hematopoietic cell transplantation for older patients with Philadelphia-positive acute lymphoblastic leukemia. A study by the Acute Leukemia Working Party of the EBMT.

Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report.

Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMT.

Impact of pre-transplant induction cycles on post-transplant outcomes in patients with ALL: a study from the ALWP EBMT

Older matched sibling donor versus young haplo-identical donor for elderly patients with acute myeloid leukemia.

Outcomes of Allogeneic HCT in Hodgkin Lymphoma in the Era of Checkpoint Inhibitors: A Joint CIBMTR and EBMT Analysis.

Superior GVHD-Free, Relapse-Free Survival for Haploidentical Transplant With PTCy Than Matched Unrelated Donor for AML Patients Transplanted in Second Complete Remission: A Study From the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML.

Impact of fludarabine dose on outcome after allo-HSCT with reduced intensity conditioning for older patients with AML

Posttransplant cyclophosphamide versus anti‐thymocyte globulin versus combination for graft‐versus‐host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

Does IPSS-R down staging before transplantation improve the prognosis of patients with Myelodysplastic neoplasms?

Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMT.

Improvements in Posttransplant Outcomes Over Two Decades in Older Patients with Acute Myeloid Leukemia in the EBMT ALWP Study.

Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT.

Lower relapse incidence with HAPLO versus MSD or MUD HCTs for AML patients with KMT2A rearrangement: a study from the Global Committee and the ALWP of the EBMT

PTCy versus CNI-based GVHD prophylaxis in HLA-matched transplants for Hodgkin Lymphoma: a study of the LWP of the EBMT.

Posttransplant cyclophosphamide versus anti-thymocyte globulin versus combination for graft-versus-host disease prevention in haploidentical transplantation for adult acute myeloid leukemia: A report from the European Society for Blood and Marrow Transplantation Acute Leukemia Working Party

CAR as Booster to Launch Allogeneic Transplantation in Refractory Leukemia.

Impact of pre-transplantation depression and anxiety on the outcome of allogeneic hematopoietic stem cell transplantation: a study from the Transplant Complications Working Party of the EBMT.

A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-Cell Stemness Shows Enhanced CAR T-Cell Efficacy in Preclinical and Early Clinical Development.

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.

Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group.

Expert consensus on microtransplant for acute myeloid leukemia in elderly patients -report from the international microtransplant interest group

ALLO HSCT IN OLDER PATIENTS: A QUESTION OF REAL PERSONALIZED MEDICINE

Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)

Collaborators (9)

Nicolas Boissel

Abdul Hamid Bazarbachi

Ibrahim Yakoub-Agha

Nelson Chao

Javier Briones Meijide

Emanuele Angelucci

Jaime Sanz

Cristina CASTILLA LLORENTE

Nicolaus Kröger

Make your next move.